Adam S. Grossman

Adam S. Grossman

President, Chief Executive Officer and DirectoratAdma Biologics· In proxies 2022–2025

Pay in FY2025+29% from the year before · Adma Biologics stock +6.4% the same year

Adam S. Grossman was paid $10.2M in FY2025 (Dec), up 29%. Adma Biologics stock rose 6.4% that year.

Pay$100 in the stock at the end of FY21 → $1.3K
Pay is from the Summary Compensation Table of each Adma Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Adma BiologicsPublic company · 4 yr
    • President, Chief Executive Officer and Director2022 – Present · 4 yrStock in role +802%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?